Profound Medical price to book ratio PROF
Market value divided by the book value of the company's net assets, since 2025.
- Today, Nov 2, 2026
- 4.9×
- Peer median
- 1.8×
Profound Medical's price to book ratio is 4.9× as of Nov 2, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 1.8×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 4.9× | 2.8× | 7.9× |
| 2025 | 6.9× | 2.3× | 7.2× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Profound Medical's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| PROFProfound Medical | 4.9× |
| UTMDUtah Medical Products | 1.8× |
| INFUInfuSystem | 4.7× |
| PDEXPro DEX | 3.7× |
| EMBCEmbecta | n/m |
| TCMDTactile Systems Technology | 2.3× |
| KEQUKewaunee Scientific | 1.3× |
| MOVMovado | 1.4× |
| IRMDIradimed | 9.5× |
| IARTIntegra Lifesciences | 1.0× |
| APTAlpha Pro Tech | 0.9× |
| Peer median | 1.8× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Profound Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.